BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38550594)

  • 1. Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy.
    Hensel J; Metts J; Gupta A; Ladle BH; Pilon-Thomas S; Mullinax J
    Cancer J; 2022 Jul-Aug 01; 28(4):322-327. PubMed ID: 35880942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future perspectives on engineered T cells for cancer.
    Posey AD; Young RM; June CH
    Trends Cancer; 2024 Jun; ():. PubMed ID: 38853073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.
    Haanen J; Los C; Phan GQ; Betof Warner A
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431608. PubMed ID: 38776509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grooved Microneedle Patch Augments Adoptive T Cell Therapy Against Solid Tumors via Diverting Regulatory T Cells.
    Zhou R; Yu H; Sheng T; Wu Y; Chen Y; You J; Yang Y; Luo B; Zhao S; Zheng Y; Li H; Zhang Y; Guo Y; Gu Z; Yu J
    Adv Mater; 2024 Jun; ():e2401667. PubMed ID: 38843541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive T cell therapy for solid tumors: current landscape and future challenges.
    Albarrán V; San Román M; Pozas J; Chamorro J; Rosero DI; Guerrero P; Calvo JC; González C; García de Quevedo C; Pérez de Aguado P; Moreno J; Cortés A; Soria A
    Front Immunol; 2024; 15():1352805. PubMed ID: 38550594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead.
    Kirtane K; Elmariah H; Chung CH; Abate-Daga D
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoantigen-specific CD4
    Hall MS; Teer JK; Yu X; Branthoover H; Snedal S; Rodriguez-Valentin M; Nagle L; Scott E; Schachner B; Innamarato P; Hall AM; Blauvelt J; Rich CJ; Richards AD; Ceccarelli J; Langer TJ; Yoder SJ; Beatty MS; Cox CA; Messina JL; Abate-Daga D; Mule JJ; Mullinax JE; Sarnaik AA; Pilon-Thomas S
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37802604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive CD8
    Jiang X; Xu J; Liu M; Xing H; Wang Z; Huang L; Mellor AL; Wang W; Wu S
    Cancer Lett; 2019 Oct; 462():23-32. PubMed ID: 31356845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions.
    Granhøj JS; Witness Præst Jensen A; Presti M; Met Ö; Svane IM; Donia M
    Expert Opin Biol Ther; 2022 May; 22(5):627-641. PubMed ID: 35414331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice.
    Forsberg EMV; Lindberg MF; Jespersen H; Alsén S; Bagge RO; Donia M; Svane IM; Nilsson O; Ny L; Nilsson LM; Nilsson JA
    Cancer Res; 2019 Mar; 79(5):899-904. PubMed ID: 30622115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome regulation of immune response mechanism: Pros and cons in immunotherapy.
    Essola JM; Zhang M; Yang H; Li F; Xia B; Mavoungou JF; Hussain A; Huang Y
    Bioact Mater; 2024 Feb; 32():124-146. PubMed ID: 37927901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma.
    Yuti P; Sawasdee N; Natungnuy K; Rujirachaivej P; Luangwattananun P; Sujjitjoon J; Yenchitsomanus PT
    Biomed Pharmacother; 2023 Dec; 168():115691. PubMed ID: 37844355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIL Therapy: Facts and Hopes.
    Monberg TJ; Borch TH; Svane IM; Donia M
    Clin Cancer Res; 2023 Sep; 29(17):3275-3283. PubMed ID: 37058256
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.